BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/6/2019 1:44:07 PM | Browse: 900 | Download: 1214
 |
Received |
|
2019-03-28 02:01 |
|
Peer-Review Started |
|
2019-03-28 08:35 |
|
To Make the First Decision |
|
2019-04-18 07:00 |
|
Return for Revision |
|
2019-05-13 03:28 |
|
Revised |
|
2019-08-01 15:55 |
|
Second Decision |
|
2019-08-16 10:26 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-08-20 04:25 |
|
Articles in Press |
|
2019-08-20 04:25 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-09-05 07:14 |
|
Publish the Manuscript Online |
|
2019-09-06 13:44 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Systematic review of ablative therapy for the treatment of renal allograft neoplasms
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Evaldo Favi, Nicholas Raison, Federico Ambrogi, Serena Delbue, Maria Chiara Clementi, Luca Lamperti, Marta Perego, Matteo Bischeri and Mariano Ferraresso |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Evaldo Favi, MD, PhD, Senior Lecturer, Surgeon, Renal Transplantation, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Francesco Sforza n.28, Milan 20122, Italy. evaldofavi@gmail.com |
| Key Words |
Ablative therapy; Cryoablation; Radiofrequency ablation; Microwave ablation; High-intensity focused ultrasonography; Irreversible electroporation |
| Core Tip |
Ablative therapy (AT) is a minimally invasive alternative to radical or partial nephrectomy for the treatment of renal allograft tumours. To date, limited data exist regarding long-term efficacy and safety. We performed a systematic review on radiofrequency ablation, cryoablation, microwave ablation, high-intensity focused ultrasound, and irreversible electroporation of neoplasms arising in the transplanted kidney and described treatment-specific and overall outcomes. In the considered cases, AT was successfully offered to all transplant recipients with benign tumours or with American Joint Committee on Cancer T1a N0 M0 renal cell carcinomas of the kidney allograft who were not suitable for more aggressive and demanding surgical treatments. |
| Publish Date |
2019-09-06 13:44 |
| Citation |
Favi E, Raison N, Ambrogi F, Delbue S, Clementi MC, Lamperti L, Perego M, Bischeri M, Ferraresso M. Systematic review of ablative therapy for the treatment of renal allograft neoplasms. World J Clin Cases 2019; 7(17):2487-2504 |
| URL |
https://www.wjgnet.com/2307-8960/full/v7/i17/2487.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v7.i17.2487 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
